Compliance and Tolerance to Oral AntiBiotherapy in Osteoarticular Infections (OTABIO)

Launched by HOSPICES CIVILS DE LYON · Jan 10, 2022

Keywords

ClinConnect Summary

The OTABIO clinical trial is studying how well patients follow their prescribed oral antibiotic treatment for bone and joint infections (BJI) and how they tolerate the medication. These infections can be serious and often require long-term antibiotic therapy, which can last at least six weeks. Unfortunately, many patients struggle with sticking to their treatment due to side effects from the antibiotics or the demands of taking them multiple times a day. This trial aims to understand these challenges better.

To participate in this study, you need to be at least 18 years old and have a diagnosed bone or joint infection that requires at least one oral antibiotic for a minimum of six weeks. Participants will be asked to share their experiences with the antibiotics they're taking, helping researchers learn more about treatment adherence. It's important to note that this study is open to everyone, regardless of gender, and is currently looking for volunteers. If you're interested, you'll need to provide a phone number for communication purposes, and you cannot be pregnant, breastfeeding, or under legal protection measures to participate.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ≥ 18 years
• • Diagnosis of osteoarticular infection
• • Treatment with at least one oral antibiotic for a minimum expected duration ≥ 6 weeks with an expected end of treatment date
• • Patient who was informed and did not object to participate in the study
• Exclusion Criteria:
• • Treatment for BJI with oral antibiotic without end of treatment date
• • treatment for BJI with parenteral antibiotic only
• • patient who doesn't have a telephone number or who doesn't want to give it
• • Adults subject to a legal protection measure
• • Pregnant or breastfeeding women